These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
163 related articles for article (PubMed ID: 20207525)
1. Fatty acids and signalling in endothelial cells. Ringseis R; Eder K Prostaglandins Leukot Essent Fatty Acids; 2010; 82(4-6):189-98. PubMed ID: 20207525 [TBL] [Abstract][Full Text] [Related]
2. Trans fatty acids - effects on systemic inflammation and endothelial function. Mozaffarian D Atheroscler Suppl; 2006 May; 7(2):29-32. PubMed ID: 16713393 [TBL] [Abstract][Full Text] [Related]
3. Prostanoid signal transduction and gene expression in the endothelium: role in cardiovascular diseases. Alfranca A; Iñiguez MA; Fresno M; Redondo JM Cardiovasc Res; 2006 Jun; 70(3):446-56. PubMed ID: 16458868 [TBL] [Abstract][Full Text] [Related]
4. Peroxisome proliferator-activated receptors and atherogenesis: regulators of gene expression in vascular cells. Marx N; Duez H; Fruchart JC; Staels B Circ Res; 2004 May; 94(9):1168-78. PubMed ID: 15142970 [TBL] [Abstract][Full Text] [Related]
5. Peroxisome proliferator-activated receptors in vascular biology-molecular mechanisms and clinical implications. Touyz RM; Schiffrin EL Vascul Pharmacol; 2006 Jul; 45(1):19-28. PubMed ID: 16782410 [TBL] [Abstract][Full Text] [Related]
6. Vascular actions of insulin with implications for endothelial dysfunction. Potenza MA; Addabbo F; Montagnani M Am J Physiol Endocrinol Metab; 2009 Sep; 297(3):E568-77. PubMed ID: 19491294 [TBL] [Abstract][Full Text] [Related]
15. A rationale for combination therapy in risk factor management: a mechanistic perspective. Mason RP Am J Med; 2005 Dec; 118 Suppl 12A():54-61. PubMed ID: 16356809 [TBL] [Abstract][Full Text] [Related]
16. Skeletal muscle and nuclear hormone receptors: implications for cardiovascular and metabolic disease. Smith AG; Muscat GE Int J Biochem Cell Biol; 2005 Oct; 37(10):2047-63. PubMed ID: 15922648 [TBL] [Abstract][Full Text] [Related]
17. The endothelium in health and in cardiovascular disease. Garćia-Palmieri MR P R Health Sci J; 1997 Jun; 16(2):136-41. PubMed ID: 9285990 [TBL] [Abstract][Full Text] [Related]
18. Caveolae and endothelial dysfunction: filling the caves in cardiovascular disease. Xu Y; Buikema H; van Gilst WH; Henning RH Eur J Pharmacol; 2008 May; 585(2-3):256-60. PubMed ID: 18423600 [TBL] [Abstract][Full Text] [Related]
19. [Role of the fatty acids in ovarian functions: involvement of peroxisome proliferator-activated receptors (PPAR) and adipokines]. Dupont J; Froment P; Ramé C; Pierre P; Coyral-Castel S; Chabrolle C Gynecol Obstet Fertil; 2008 Dec; 36(12):1230-8. PubMed ID: 19013096 [TBL] [Abstract][Full Text] [Related]
20. Omegacoeur, a Mediterranean nutritional complement, stimulates Na,K-ATPase activity in human endothelial cells. Duran MJ; Sabatier F; Pieroni G; Gerber G; Sampol J; Maixent JM Cell Mol Biol (Noisy-le-grand); 2001 Mar; 47(2):313-8. PubMed ID: 11355006 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]